ABSTRACT
Stevia rebaudiana Bertoni, a plant from South America and indigenous of Paraguay, has shown several biological effects and healthy properties, although it is especially used in South America and some Asiatic regions. In addition, it is a natural sweetener, almost 300 times sweeter than sucrose, being attributed to its phytoconstituents prominent antioxidant, antimicrobial, antidiabetic (antihyperglycemic, insulinotropic, and glucagonostatic), antiplatelet, anticariogenic, and antitumor effects. In this sense, this work aims to provide an extensive overview on the historical practices of stevia and its effects in human health based on its chemical composition and applications for both food and pharmaceutical industries.
Subject(s)
Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Stevia , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Clinical Trials as Topic/methods , Diterpenes, Kaurane/isolation & purification , Diterpenes, Kaurane/pharmacology , Diterpenes, Kaurane/therapeutic use , Drug Evaluation, Preclinical , Glucosides/isolation & purification , Glucosides/pharmacology , Glucosides/therapeutic use , Humans , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/therapeutic use , Plant Extracts/chemistry , Plant Leaves/chemistry , Plant Leaves/physiology , Stevia/chemistry , Stevia/physiology , Sweetening Agents/chemistry , Sweetening Agents/pharmacology , Sweetening Agents/therapeutic useABSTRACT
Candida albicans has the ability to adapt to different host niches, often glucose-limited but rich in alternative carbon sources. In these glucose-poor microenvironments, this pathogen expresses JEN1 and JEN2 genes, encoding carboxylate transporters, which are important in the early stages of infection. This work investigated how host microenvironments, in particular acidic containing lactic acid, affect C. albicans biofilm formation and antifungal drug resistance. Multiple components of the extracellular matrix were also analysed, including their impact on antifungal drug resistance, and the involvement of both Jen1 and Jen2 in this process. The results show that growth on lactate affects biofilm formation, morphology and susceptibility to fluconazole and that both Jen1 and Jen2 might play a role in these processes. These results support the view that the adaptation of Candida cells to the carbon source present in the host niches affects their pathogenicity.